TCG Crossover GP I, LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-01 4:14 pm Sale |
2024-03-28 | 13D | KalVista Pharmaceuticals, Inc. KALV |
TCG Crossover GP I, LLC | 1,345,826 3.200% |
-1,355,014 (-50.17%) |
Filing |
| 2024-02-20 4:49 pm Sale |
2024-02-07 | 13D | KalVista Pharmaceuticals, Inc. KALV |
TCG Crossover GP I, LLC | 2,700,840 6.520% |
-707,241 (-20.75%) |
Filing |
| 2023-01-09 4:19 pm Purchase |
2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV |
TCG Crossover GP I, LLC | 3,408,081 9.900% |
3,408,081 (New Position) |
Filing |